Corticosteroid treatment in XXXX with a three-year follow-up period.

@entity1 @entity1127 @entity2715 @entity1412 @entity617
OBJECTIVES/HYPOTHESIS: The management of @entity1412 is undoubtedly a controversial subject. The part played by surgery seems to be steadily growing, if the number of published reports dedicated to this approach is any yardstick. Although the medical treatment remains the undisputed therapeutic mainstay, trials dedicated to the long-term assessment of its overall efficacy are scarce. STUDY DESIGN: Retrospective medical record review. METHODS: The aim of the study is focused on the evaluation of a dual modality, topical and systemic, over a follow-up period of 3 years. In all, 100 @entity1 were treated according to a standardized therapeutic protocol combining short-term oral administration of @entity617 and daily intranasal spray of @entity2715 . RESULTS: Over the follow-up period of 3 years, this dual modality proved to be successful in 85% of the @entity1 ; only 15% had to undergo surgery after its failure. The average symptom reduction reached an improvement rate varying from 58% to 80%, according to the symptom type. The daily dosage of @entity617 and @entity2715 was progressively decreased while the gain in nasal comfort was being preserved. CONCLUSIONS: Management of nasal @entity1127 should be primarily medical. Resorting to surgical procedures should not be envisaged before a trial is conducted of dual steroid therapy under a regimen of strict compliance to treatment.
